ABIVAX to present at the Biotech Showcase during the JP Morgan Healthcare Conference
ABIVAX to present at the Biotech Showcase during the JP Morgan Healthcare Conference
December 17, 2015
Download 97.9 KB
Paris, France, December 17th, 2015 – ABIVAX (Euronext Paris: FR0012333284 – ABVX), an emerging leader in developing and commercializing anti-viral drugs and therapeutic vaccines for diseases like HIV/AIDS and chronic hepatitis B (CHB), today announced that its CEO, Prof. Hartmut Ehrlich, M.D., will present at the Biotech Showcase™ Annual Conference, to be held in San Francisco on January 11-13, 2016.